C. Difficile

>

Latest News

Fecal Transplant Benefits C diff Patients Coinfected With COVID-19
Fecal Transplant Benefits C diff Patients Coinfected With COVID-19

February 4th 2023

Treating Clostridioides difficile infection is complicated in patients coinfected with COVID-19. However, a new study suggests a significant benefit of fecal microbiota transplant (FMT) in these coinfected patients.

When is Fidaxomicin Cost Effective for Treating Recurrent C Difficile?
When is Fidaxomicin Cost Effective for Treating Recurrent C Difficile?

January 25th 2023

What Makes Fecal Microbiota Transplant an Effective C Difficile Cure?
What Makes Fecal Microbiota Transplant an Effective C Difficile Cure?

January 16th 2023

An Exciting Time in CDI: Approvals, Approaches and Anticipation
An Exciting Time in CDI: Approvals, Approaches and Anticipation

January 13th 2023

Bad Bugs, New Drugs: A Discussion of Selected New Therapeutics From IDWeek 2022
Bad Bugs, New Drugs: A Discussion of Selected New Therapeutics From IDWeek 2022

December 24th 2022

Video Series
Video Interviews
Podcasts

More News

© 2023 MJH Life Sciences

All rights reserved.